Skip to main content
. 2019 Sep 30;33(6):2657–2664. doi: 10.1111/jvim.15590

Table 1.

Clinicopathological characteristics of cats grouped according to SDMA status

SDMA within RI (n = 107) n SDMA above RI (n = 36) n P value
SDMA (1‐14 μg/dL) 10 [10, 11] 107 15 [15, 19] 36
Age (years) 12.2 [11.2, 14.5] 107 14 [12.1, 15.3] 36 .66
Weight (kg) 4.35 [3.36, 5.08] 107 4.01 [3.02, 4.85] 36 .22
BCS (1‐9) 5 [4, 6] 107 5 [3, 5] 36 .19
MCS (0‐2) 1 [1, 2] 105 1 [1, 1] 36 .06
Sex (male n [%]) 40 107 54 36 .25
PCV (%) 38 [25, 40] 106 35 [33, 40] 36 .12
Creatinine (0.23‐2.00 mg/dL) 1.49 [1.31, 1.67] 107 1.76 [1.59, 1.89] 36 <.001
FGF23 (56‐700) pg/mL) 155 [127, 243] 107 271 [176, 523] 36 <.001
PTH (2.6‐17.6 pg/mL) 7 [2.6, 11.3] 44 7.3 [4.1, 9.3] 10 .84
Phosphate (2.71‐6.89 mg/dL) 3.66 [3.22, 4.12] 107 3.84 [3.28, 4.18] 36 .40
Total calcium (8.22‐11.82 mg/dL) 9.7 [9.3, 10.1] 107 9.98 [9.5, 10.18] 36 .70
Total magnesium (1.73‐2.57 mg/dL) 2.14 [2.04, 2.26] 36 1.97 [1.87, 2.21] 5 .62

Note: Data presented as median [25th, 75th percentile] or prevalence (n [%]).

Abbreviations: BCS, body condition score; FGF23, fibroblast growth factor 23; MCS, muscle condition score; PCV, packed cell volume; PTH, parathyroid hormone; RI, reference interval; SDMA, symmetric dimethylarginine.